Adlai Nortye (ANL) Assets Average (2023 - 2025)
Adlai Nortye (ANL) reported Assets Average of $53.2 million for Q4 2025, down 40.5% year-over-year from $89.5 million in Q4 2024, and down 25.7% on a QoQ basis from $71.7 million in Q2 2025.
Adlai Nortye (ANL) has 3 years of Assets Average data on file, last reported at $53.2 million in Q4 2025.
- Quarterly Assets Average fell 40.5% year-over-year to $53.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $53.2 million (down 40.5% YoY) and the FY2025 annual result came in at $52.9 million, down 47.53% from the prior year.
- Assets Average declined to $53.2 million in Q4 2025 per ANL's latest filing, from $71.7 million in the prior quarter.
- Across five years, Assets Average topped out at $118.9 million in Q2 2024 and bottomed at $53.2 million in Q4 2025.
- The 3-year median for Assets Average is $89.5 million (2024), against an average of $86.9 million.
- The widest annual swing landed in 2024, when Assets Average dropped 11.75%; it then sank 40.5% in 2025.
- Tracing ANL's Assets Average over 3 years: stood at $101.4 million in 2023, then decreased by 11.75% to $89.5 million in 2024, then slumped by 40.5% to $53.2 million in 2025.
- Per Business Quant, the three latest ANL Assets Average figures stand at $53.2 million (Q4 2025), $71.7 million (Q2 2025), and $89.5 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 40.71 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 26.03 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Adlai Nortye | 23,840.00 | -8.03 Mn | - | 53.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53.24 Mn |
| Jun 30, 2025 | 71.66 Mn |
| Dec 31, 2024 | 89.48 Mn |
| Jun 30, 2024 | 118.94 Mn |
| Dec 31, 2023 | 101.39 Mn |